Skip to main content

Table 4 Availability of anti-malarial drugs in Sierra Leone (127 outlets surveyed), by public, charitable and private sectors

From: Anti-malarial market and policy surveys in sub-Saharan Africa

  Number of anti-malarials in outlets surveyed (n=340) Number of anti-malarials in government/public sector (n=141) Number of anti-malarials in mission/NGO (n=67) Number of anti-malarials in the private sector(n=132)
AM+LUM 3 (0.9%) 0 1 (1.5%) 2 (1.5%)
AQ 8 (2.4%) 1 (0.7%) 1 (1.5%) 6 (4.5%)
AR 13 (3.8%) 3 (2.1%) 4 (6.0%) 6 (4.5%)
AS 15 (4.4%) 2 (1.4%) 3 (4.5%) 10 (7.6%)
AS+AQ 100 (29.4%) 55 (39.0%) 20 (29.9%) 25 (18.9%)
AS+MQ 1 (0.3%) 0 0 1 (0.8%)
AS+SP 6 (1.8%) 0 1 (1.5%) 5 (3.8%)
Chloroquine 35 (10.3%) 0 4 (6.0%) 31 (23.5%)
Halofantrine 3 (0.9%) 0 0 3 (2.3%)
MQ 3 (0.9%) 0 1 (1.5%) 2 (1.5%)
Proguanil 1 (0.3%) 0 0 1 (0.8%)
Pyrimethamine 1 (0.3%) 0 0 1 (0.8%)
Quinine 67 (19.7%) 36 (25.5%) 16 (23.9%) 15 (11.4%)
SP 84 (24.7%) 44 (31.2%) 16 (23.9%) 24 (18.2%)
  1. Data are n (%).